Artivion | CRY - Capital De Empréstimo





Capital De Empréstimo Alterar Data
Abbott USD 29.64B 19.74B 2026-03
Accuray USD 124.78M 2.54M 2025-12
AngioDynamics USD 5.6M 100K 2025-09
Artivion USD 363.42M 148.07M 2026-06
AtriCure USD 61M 0 2026-06
Baxter International USD 8.62B 6M 2026-06
Becton, Dickinson and Co. USD 13.51B 1.2B 2026-06
Boston Scientific USD 10.86B 148M 2026-03
Edwards Lifesciences USD 598.7M 1.3M 2026-06
Inogen USD 0 0 2022-06
Integra LifeSciences USD 1.83B 2.05M 2026-06
J&J USD 37.34B 183M 2026-06
Mesa Laboratories USD 104.2M 104.3M 2024-09
Orthofix International USD 221.59M 256K 2026-06
Pfizer USD 60.5B 70M 2026-06
ResMed USD 399.42M 4.75M 2026-06
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 809K 2026-06
Teleflex USD 2.72B 206.24M 2026-06
Terumo JPY 209.52B 109.61B 2026-06
Trinity Biotech USD 16.33M 98.53M 2025-12